8:30-10:30 -
[-]2007 World Congress
--->Organising Committees
--->Sponsors
--->Downloads
--->Important Dates
[-]Programme
--->Saturday
--->Sunday
--->Monday
--->Tuesday
--->Social Programme
[-]Travel & Location
--->Congress & Meeting Venues
--->Accommodation
--->[-]All about Dresden
--->Getting to Dresden
--->Cultural Entertainment
--->Sightseeing in Dresden
--->Food & Drink in Dresden
--->Links
--->Contact
TUESDAY, 11 SEPTEMBER, 2007 (Concurrent Sessions WFN & IHA)
Hall 1, Hall 4 and Meeting Room 1
8:30-10:30
Scientific Session IV: Cell Replacement in HD
Chairs:Elena Cattaneo (Milan, Italy), Alexander Storch (Dresden, Germany)
8:30Transplantation Studies in Animal Models of HD
Stephen Dunnett (Cardiff, UK)
9:00Clinical Transplantation in HD–Long-Term Results
Anne-Catherine Bachoud-Lévi (Créteil, France)
9:30Clinical Transplantation in HD – the European Extension
Guido Nikkhah (Freiburg, Germany)
10:00Cell Replacement through Striatal Neurogenesis
Tomas Deierborg (Lund, Sweden)
Clinical Session IV: Recent and Upcoming Clinical Studies/Trials in HD
Chairs:Christoph Kosinski (Aachen, Germany), Dan van Kammen (New York, USA)
8:30A Novel Observational Study: Track-HD
Sarah Tabrizi (London, UK)
8:40Therapeutics for Huntington’s Disease: a Systematic Review
Tiago Mestre (Lisbon, Portugal)
8:50Treatment of Irritability/Apathy/Sleeplessness
David Craufurd (Manchester, UK), Joseph Priller (Berlin, Germany)
9:00Atomoxtine
Leigh J. Beglinger (Iowa, USA)
9:10A Randomized, Controlled Trial of Ethyl-EPA for the Treatment of Huntington’s Disease - Preliminary Results
E. Ray Dorsey, Tony Clarke (Rochester, USA)
9:30ACR16, a Dopaminergic Stabilizer for the Symptomatic Treatment of Huntington Disease
Joachim Tedroff (Göteborg, Sweden)
9:40High Dose Creatine for Huntington’s Disease. Biomarkers Enable Dose Determination
Steven Hersch (Charlestown, USA)
9:50Cysteamine in HD
Christophe Verny (Angers, France)
10:00A Randomised, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study Using Nabilone for Symptomatic Relief in Patients with Huntington’s Disease
Adrienne Curtis (Birmingham, UK)
10:10CARE-HD2
Karl Kieburtz (Rochester, USA)
10:20A Study in Premanifest Huntington’s Disease of Coenzyme Q10 (Ubiquinone)
Kevin Biglan (Rochester, USA)
IHA Session IV: Quality of Life in Patients with Huntington's Disease
Chair:Gerrit Dommerholt (Harfsen, The Netherlands)
8:30Development of a Disease-Specific Quality of Life Instrument for People with Huntington's Disease: Hearing what Patients Say
Aileen Ho, Mevhibe Hocauglu (Reading, UK)
Building up Support Systems for Families and Persons with HD
Don Lamont, John Stainsby (HSC Canada)
Support Systems in Northern Germany
Gabriele Ritter (Heiligenhafen, Germany), Michael Orth (Hamburg, Germany)

Back to Overview
8:30-10:3011:00-13:0014:00-15:0015:00-17:00